MetaStat plans up to $12 million public offering of common stock

Company to grant underwriter H.C. Wainwright 45-day greenshoe

By Marisa Wong

Morgantown, W.Va., Oct. 13 – MetaStat, Inc. plans to raise up to $12 million through a public offering of common stock, according to an S-1 filing with the Securities and Exchange Commission.

The deal will include a 45-day greenshoe.

H.C. Wainwright & Co., LLC is the underwriter.

Proceeds will be used to continue clinical development and testing and for working capital and general corporate purposes.

On Oct. 8, the last reported sale price of the company’s common stock was $4.65 (OTCQB: MTST).

The Boston-based molecular diagnostic company intends to list its common stock on the Nasdaq Capital Market.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.